Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares OutstandingShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Arrowhead Pharmaceuticals (ARWR) Shares Outstanding (2016 - 2025)

Historic Shares Outstanding for Arrowhead Pharmaceuticals (ARWR) over the last 16 years, with Q2 2025 value amounting to $138.1 million.

  • Arrowhead Pharmaceuticals' Shares Outstanding rose 1120.29% to $138.1 million in Q2 2025 from the same period last year, while for Jun 2025 it was $138.1 million, marking a year-over-year increase of 1120.29%. This contributed to the annual value of $124.4 million for FY2024, which is 1590.13% up from last year.
  • As of Q2 2025, Arrowhead Pharmaceuticals' Shares Outstanding stood at $138.1 million, which was up 1120.29% from $138.1 million recorded in Q1 2025.
  • Over the past 5 years, Arrowhead Pharmaceuticals' Shares Outstanding peaked at $138.1 million during Q2 2025, and registered a low of $104.0 million during Q1 2021.
  • Its 5-year average for Shares Outstanding is $113.5 million, with a median of $107.0 million in 2023.
  • As far as peak fluctuations go, Arrowhead Pharmaceuticals' Shares Outstanding surged by 110.4% in 2023, and later surged by 1615.44% in 2024.
  • Arrowhead Pharmaceuticals' Shares Outstanding (Quarter) stood at $104.8 million in 2021, then grew by 1.28% to $106.1 million in 2022, then increased by 1.28% to $107.5 million in 2023, then rose by 15.96% to $124.7 million in 2024, then rose by 10.82% to $138.1 million in 2025.
  • Its last three reported values are $138.1 million in Q2 2025, $138.1 million for Q1 2025, and $124.7 million during Q4 2024.